NCT05497947 (SOAL-VF) is a clinical trial in Pharyngeal Cancer, sponsored by Centre Hospitalier de Valence.

Who is sponsoring NCT05497947?

NCT05497947 is sponsored by Centre Hospitalier de Valence.

What condition does NCT05497947 study?

NCT05497947 studies Pharyngeal Cancer, Swallowing Disorder, Larynx Cancer.

Is NCT05497947 still recruiting?

NCT05497947 is currently completed. Last updated 8 September 2025.

Last reviewed 2025-09-08 · How we verify

NCT05497947: SOAL-VF

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of the French Translation of Swallowing (SOAL-VF) Patient Reported Outcomes (PRO) After Total PharyngoLaryngectomy

Completed Last updated 8 September 2025

What this trial tests

trial in Pharyngeal Cancer in 225 participants. Completed in 3 July 2023.

Timeline

3 July 2021

Primary endpoint
5 July 2022

3 July 2023

Quick facts

Lead sponsor	Centre Hospitalier de Valence
Status	Completed
Study type	OBSERVATIONAL
Enrollment	225
Start date	3 July 2021
Primary completion	5 July 2022
Estimated completion	3 July 2023
Sites	1 location across France

Conditions studied

Pharyngeal Cancer — all drugs for Pharyngeal Cancer →
Swallowing Disorder — all drugs for Swallowing Disorder →
Larynx Cancer — all drugs for Larynx Cancer →

Sponsor

Centre Hospitalier de Valence

Who can join

18 and older, any sex, with Pharyngeal Cancer or Swallowing Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A monocentric study to evaluate the french translation of Swallowing (SOAL-VF) Patient Reported Outcomes (PRO) after Total PharyngoLaryngectomy

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Centre Hospitalier de Valence trials

Trials by the same sponsor.

NCT06184880 — Effect of Physical Activity Program on Sedentary of Patients With Upper Aerodigestive Tract Cancer · NA · recruiting
NCT05618392 — Pain Assessment Following Placement of a Percutaneous Radiologic Gastrostomy and Predictive Factors · recruiting
NCT05227157 — GOUTMETALSAIN: Comparison of the Perception of Metallic Taste According to Lingual Locations in Healthy Volunteers · completed
NCT05150470 — Evaluation of the Dental Movements Caused by Oral Appliance in Sleep Apnea Syndrome · NA · completed
NCT05056766 — How Does the Clinical and Paraclinical Efficacy of an Oral Appliance Evolved According to Propulsion: Control With Each · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05497947 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier de Valence
Last refreshed: 8 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05497947.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing